MILIC, Jovana
 Distribuzione geografica
Continente #
NA - Nord America 7.440
EU - Europa 3.774
AS - Asia 3.509
SA - Sud America 433
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 134
OC - Oceania 35
Totale 15.463
Nazione #
US - Stati Uniti d'America 7.064
IT - Italia 1.546
SG - Singapore 1.060
CN - Cina 795
GB - Regno Unito 520
HK - Hong Kong 395
VN - Vietnam 340
BR - Brasile 315
SE - Svezia 305
DE - Germania 251
CA - Canada 235
BD - Bangladesh 219
FI - Finlandia 213
RU - Federazione Russa 206
FR - Francia 186
KR - Corea 115
IN - India 114
NL - Olanda 78
ES - Italia 73
ID - Indonesia 70
JP - Giappone 58
MX - Messico 50
ZA - Sudafrica 45
AR - Argentina 42
BG - Bulgaria 42
TR - Turchia 42
CH - Svizzera 39
IQ - Iraq 39
SI - Slovenia 38
AE - Emirati Arabi Uniti 31
UA - Ucraina 31
BE - Belgio 30
IE - Irlanda 29
IL - Israele 29
AU - Australia 28
IR - Iran 28
LT - Lituania 28
PK - Pakistan 28
PL - Polonia 27
PH - Filippine 23
CO - Colombia 22
RO - Romania 22
SA - Arabia Saudita 22
UG - Uganda 22
MY - Malesia 18
CR - Costa Rica 15
EG - Egitto 15
TW - Taiwan 15
RS - Serbia 14
VE - Venezuela 14
CL - Cile 13
EC - Ecuador 13
HN - Honduras 12
NO - Norvegia 12
SV - El Salvador 12
GR - Grecia 11
UZ - Uzbekistan 11
AT - Austria 10
JM - Giamaica 10
AZ - Azerbaigian 9
MA - Marocco 9
CZ - Repubblica Ceca 8
KE - Kenya 8
SC - Seychelles 8
DK - Danimarca 7
GT - Guatemala 7
KZ - Kazakistan 7
LB - Libano 7
NZ - Nuova Zelanda 7
AL - Albania 6
DO - Repubblica Dominicana 6
EE - Estonia 6
PE - Perù 6
TN - Tunisia 6
CW - ???statistics.table.value.countryCode.CW??? 5
ET - Etiopia 5
GP - Guadalupe 5
HR - Croazia 5
KG - Kirghizistan 5
NP - Nepal 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
GE - Georgia 4
HU - Ungheria 4
KH - Cambogia 4
NI - Nicaragua 4
PR - Porto Rico 4
PY - Paraguay 4
BB - Barbados 3
BY - Bielorussia 3
CG - Congo 3
DZ - Algeria 3
JO - Giordania 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 15.296
Città #
Ashburn 893
Santa Clara 686
Singapore 671
Chandler 443
San Jose 434
Fairfield 431
Hong Kong 362
Council Bluffs 322
Hefei 253
Woodbridge 228
Nyköping 219
Helsinki 195
Seattle 184
Southend 171
London 162
New York 162
Houston 159
Cambridge 151
Milan 135
Modena 135
Los Angeles 133
Wilmington 131
Dallas 130
Beijing 125
Ho Chi Minh City 116
Rome 114
Seoul 98
Bologna 89
Chicago 85
The Dalles 85
Hanoi 79
Lauterbourg 60
Buffalo 58
San Diego 58
Toronto 57
Ann Arbor 55
Jakarta 53
Frankfurt am Main 49
Munich 48
Shanghai 47
Montreal 46
Dearborn 44
Princeton 43
Tokyo 42
São Paulo 40
Boardman 39
Moscow 39
Sofia 39
North York 38
St. Petersburg 35
Phoenix 33
Florence 29
Atlanta 28
Bremen 28
Jacksonville 28
Amsterdam 27
Orem 27
Dublin 26
Salt Lake City 26
Zarautz 26
Brussels 25
Naples 25
Denver 24
Brooklyn 23
Roncoferraro 22
Nuremberg 21
Piacenza 21
Kampala 20
Vinovo 20
Chennai 19
Düsseldorf 18
Portsmouth 18
Cape Town 17
Dammam 17
Mexico City 17
Redwood City 17
Sydney 17
Birmingham 16
Bucharest 16
Eugene 16
Parma 16
Stockholm 16
Warsaw 16
Washington 16
Kent 15
Perugia 15
Secaucus 15
Baghdad 14
Beauharnois 14
Isfahan 14
Poplar 14
Columbus 13
Johannesburg 13
Monza 13
North Bergen 13
Paris 13
Redondo Beach 13
San Francisco 13
Tampa 13
Turin 13
Totale 9.420
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 540
Data-driven vs knowledge-driven inference of health outcomes in the ageing population: A case study 490
La sarcopenia nell’anziano con HIV 471
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 462
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS 399
Machine learning algorithm to predict weight change in ART experienced PWH 387
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 386
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 368
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 358
Changes in central adipose tissue after switching to integrase inhibitors 355
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV 346
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 344
Non–alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV 337
The pathway of NAFLD vs MAFLD toward significant fibrosis 336
The interplay between frailty and intrinsic capacity in aging and HIV infection 336
Predicting Respiratory Failure in Patients with COVID-19 pneumonia: a case study from Northern Italy 335
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 328
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 318
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 303
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients 288
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 285
Machine learning algorithm to predict >5% weight gain in PWH switching to INSTI 281
From NAFLD to MAFLD: implications of change in terminology in PWH 277
What is the measure of success in HIV? The fourth 90: quality of life or healthy aging? 275
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure 268
Relazioni chiave tra steatosi epatica, insulino-resistenza, diabete mellito, fragilità, terapia antiretrovirale basata sugli inibitori dell'integrasi e aumento di peso nelle persone che vivono con HIV 257
Managing antiretroviral therapy in the elderly HIV patient 255
The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study 251
Machine learning algorithm to predict >5% Weight Gain in PWH switching to InSTI 250
Aging with HIV 248
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV 248
Non-alcoholic to metabolic associated fatty liver disease: Cardiovascular implications of a change in terminology in patients living with HIV 243
Sex Differences in People Aging With HIV 242
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era 241
Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens 238
Characteristics of long COVID among older adults: a cross-sectional study 223
Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV 222
Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life 216
From NAFLD to MAFLD: implications of change in terminology in PWH 212
AKI in hospitalized patients with COVID-19: a single-center experience 211
The pathway of NAFLD vs MAFLD toward significant fibrosis 209
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons 209
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 208
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study 190
Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway 187
Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and chemiluminescent immunoassay for sex steroids assay 177
Why am I getting fat? Exploring immune-metabolic pathways to central fat accumulation in persons with HIV 160
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 158
Vitamin e as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: What is waiting on the other side of the bridge? 144
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 144
A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus 143
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 128
Distilling Clinical Scores with Symbolic Machine Learning: Frailty Index, an HIV Cohort Case Study 123
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients 121
Late HIV diagnosis - a tale of successes and failures 111
Prevalence and risk factors of cognitive frailty in people with HIV 97
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years 89
A multidisciplinary, AI‐supported quality improvement intervention to manage polypharmacy in aging people with HIV. 87
Association Between Reduced Daily Protein Intake and Sarcopenic Obesity in Men Living with HIV: A New Screening Tool 83
Health profiles of foreign-born elderly women with HIV in Italy 73
Introducing the WHO ICOPE approach into HIV care: A perspective on healthy ageing in people living with HIV 49
A Machine learning approach to predict Weight change in ART experienced PLWH 44
Cognitive and fine motor performance in people above 65 years of age with and without HIV 39
FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening study 34
Reshaping long COVID care through patient-reported needs 26
Totale 15.463
Categoria #
all - tutte 61.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022709 0 0 0 0 52 92 37 50 102 98 171 107
2022/20231.831 158 227 195 153 194 158 117 177 167 39 140 106
2023/20241.251 70 99 79 154 170 131 92 110 49 56 98 143
2024/20252.647 84 65 69 194 469 389 180 141 358 165 224 309
2025/20265.201 371 234 356 585 757 363 633 248 477 459 380 338
2026/20271.665 276 258 330 675 126 0 0 0 0 0 0 0
Totale 15.463